Increased ATP generation in the host cell is required for efficient vaccinia virus production by Chang, Chia-Wei et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Journal of Biomedical Science
Open Access Research
Increased ATP generation in the host cell is required for efficient 
vaccinia virus production
Chia-Wei Chang1, Hui-Chun Li1,2, Che-Fang Hsu3, Chiao-Yen Chang3 and 
Shih-Yen Lo*1,2,3,4
Address: 1Graduate Institute of Molecular and Cellular Biology, Tzu Chi University, Hualien, Taiwan, Republic of China, 2Graduate Institute of 
Medical Sciences, Tzu Chi University, Hualien, Taiwan, Republic of China, 3Graduate Institute of Medical Biotechnology, Tzu Chi University, 
Hualien, Taiwan, Republic of China and 4Department of Laboratory Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Republic of 
China
Email: Chia-Wei Chang - jiawei0823@mail.tcu.edu.tw; Hui-Chun Li - huichun@mail.tcu.edu.tw; Che-Fang Hsu - Huicf0313@mail.tcu.edu.tw; 
Chiao-Yen Chang - 93323102@stmail.tcu.edu.tw; Shih-Yen Lo* - losylo@mail.tcu.edu.tw
* Corresponding author    
Abstract
To search for cellular genes up-regulated by vaccinia virus (VV) infection, differential display-
reverse transcription-polymerase chain reaction (ddRT-PCR) assays were used to examine the
expression of mRNAs from mock-infected and VV-infected HeLa cells. Two mitochondrial genes
for proteins that are part of the electron transport chain that generates ATP, ND4 and CO II, were
up-regulated after VV infection. Up-regulation of ND4 level by VV infection was confirmed by
Western blotting analysis. Up-regulation of ND4 was reduced by the MAPK inhibitor, apigenin,
which has been demonstrated elsewhere to inhibit VV replication. The induction of ND4
expression occurred after viral DNA replication since ara C, an inhibitor of poxviral DNA
replication, could block this induction. ATP production was increased in the host cells after VV
infection. Moreover, 4.5 μM oligomycin, an inhibitor of ATP production, reduced the ATP level 13
hr after virus infection to that of mock-infected cells and inhibited viral protein expression and virus
production, suggesting that increased ATP production is required for efficient VV production. Our
results further suggest that induction of ND4 expression is through a Bcl-2 independent pathway.
Background
Vaccinia virus (VV), a member of the Poxviridae family, is
an enveloped, DNA virus with a genome of 192 kb encod-
ing about 200 proteins [1]. Various cell lines can be
infected by VV, including HeLa, CV-1, mouse L, and
chicken CEF cells [2,3]. VV causes major changes in host
cell machinery shortly after infection, and cytopathic
effects (CPE) are observed several hours after infection
with VV [2-4]. VV infection modulates host cell gene
expression: several previous studies have shown that
mRNA synthesis in the host cells was inhibited immedi-
ately after VV infection [5,6]. Microarray analysis showed
that around 90% of the host genes were down-regulated
after VV infection, including genes involved in DNA repli-
cation, transcription, translation, apoptosis, and the pro-
teasome-ubiquitin degradation pathway [7,8]. Only a
smaller fraction of host genes were up-regulated after VV
infection, including WASP protein, and genes implicated
in immune responses [7,8].
Several viral factors of VV utilize ATP and several steps in
viral multiplication of VV require ATP [9-14]. ATP is also
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required for DNA packaging and capsid maturation of
herpes simplex virus, for capsid assembly and release of
type D retrovirus, for capsid assembly of human immun-
odeficiency virus, and for budding of influenza virus [15-
18]. Therefore, it was expected that viral factors would
modulate cellular energetics to benefit the virus, though
this area is understudied [19].
In this study, the possible up-regulation of host cell genes
after VV infection was analyzed by differential display-
reverse transcriptase-polymerase chain reaction (ddRT-
PCR), a simple technique with high sensitivity and specif-
icity http://www.seegene.com. Two mitochondrial genes
involved in the electron transport chain (ND4 and COII)
to generate ATP were found to be up-regulated after VV
infection using this assay.
Materials and methods
Cell culture
HeLa cells, MDCK cells, HuH7 cells and Con1 cells with
full-length HCV genome were cultured in Dulbecco's
modified Eagle's medium (DMEM) containing 10% fetal
bovine serum (FBS),100 U/ml penicillin and 100 μg/ml
streptomycin (Gibco, USA) [20]. HCV sub-genomic repli-
con cells were cultured in DMEM with 10% FBS, 100 U/
ml penicillin, 100 μg/ml streptomycin, and 400 μg/ml
G418 [21]. HepG2 and 1.3 × ES2 HepG2 (HBV) were cul-
tured in DMEM containing 10% FBS, 100 U/ml penicil-
lin,100 μg/ml streptomycin and 1% non-essential amino
acids (Gibco, USA) [22]. All cultured cells were main-
tained at 37°C with 5% CO2.
Virus infection
Vaccinia virus WR strain was used to infect HeLa cells in
this study, following previously published procedures for
virus amplification and plaque assay [23,24]. Cytosine
arabosinide (ara C), where used, was added to the cells at
a concentration of 40 μg/ml [25].
Influenza A virus WSN33 was used to infect MDCK cells
following previously published procedures for virus
amplification and plaque assay [26].
Plasmid construction and DNA transfection
To clone the DNA fragment for N1L gene coding region,
vaccinia genomic DNA was used as template and forward
and reverse PCR primers (5'-CGGAATTCATGAGGACTC-
TACTTAT-3' and 5'-TGCTCTAGATTTTTCACCATATA-
GATC-3') were used to amplify the gene fragment. After
PCR, the DNA fragment was digested by restriction
enzymes (EcoRI/XbaI) and cloned into the expression vec-
tor pcDNA3.1-V5-His A (linearized by EcoRI/XbaI). This
expression plasmid was verified by sequencing. An Exgen
500 kit (Fermentas, USA) was used to transfect DNA into
HeLa cells following the manufacturer's instructions.
RNA extraction and ddRT-PCR
Total RNAs were extracted from HeLa cells 21 hr after VV
infection (MOI = 1) using an RNeasy Mini kit (Qiagen,
Germany) following the manufacturer's instructions. The
ddRT-PCR assay was performed using a GeneFishing DEG
Premix kit (Seegene, Korea), following the manufacturer's
instructions.
Western blotting analysis
Our previous procedures were followed for Western blot-
ting analysis [27,28]. A rabbit polyclonal antibody against
ERK-2, a mouse monoclonal antibody against Bcl-2 and
goat antibodies against ND4 and COII were purchased
from Santa Cruz Biotechnology (USA). Antibodies against
SDHA, ATP5O, SDHB, COVc were purchased from Abcam
company (UK). Rabbit antibodies against vaccinia viral
proteins (A type inclusion protein and IMV heparin bind-
ing surface protein) were generated in the lab.
Measurement of ATP production
Ten hours after 2 × 105 HeLa cells were seeded in one 35-
mm culture dish, cells were infected with VV (MOI = 1 or
5). Intracellular ATP was then analyzed at different time
points (virus-infected cells versus non-infected cells)
using the ATP bioluminescence assay kit HS II (Roche,
Germany) to determine ATP.
RNAi experiments
RNAi experiments were performed using the lentiviral
expressing system http://rnai.genmed.sinica.edu.tw, fol-
lowing the manufacturer's instructions. RNAi reagents
were obtained from the National RNAi Core Facility
located at the Institute of Molecular Biology/Genomic
Research Center, Academia Sinica.
Results
Elevated expression of mitochondrial genes ND4 and 
COII after vaccinia virus infection
To search for cellular genes up-regulated after vaccinia
virus infection, ddRT-PCR assay was performed to exam-
ine the expression levels of mRNAs from mock-infected
and infected HeLa cells (Additional file 1). Four DNA frag-
ments differentially expressed after virus infection were
cloned: two fragments were VV genes while the other two
were the mitochondrial genes ND4 and COII. Induction
of ND4 expression in HeLa cells by VV infection was also
confirmed by Western blotting (Fig. 1A). ND4 protein
expression in HeLa cells increased 10 hr after vaccinia
virus infection. Furthermore, up-regulation of ND4
expression by VV infection was also observed in HuH7
cells (Fig. 1B). Thus, the expression of the mitochondrial
gene ND4 was up-regulated after VV infection in different
host cells. Similar up-regulation of host ND4 expression
was not detected when VV was heat-inactivated before
infection (Fig. 1A), after influenza A virus infection, or inJournal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
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the presence of hepatitis B viral genome or hepatitis C
viral RNA (Additional file 2).
Apigenin and AraC blocked ND4 induction after vaccinia 
virus infection
Previous studies have shown that the VV-stimulated
mitogen-activated protein kinase (MAPK) pathway is
required for virus multiplication [25,29]. The MAPK path-
way inhibitor apigenin was used to analyze the effect of
MAPK blockade on the up-regulation of ND4 expression
following VV infection (Fig. 2A) [30]. Apigenin (45 uM)
significantly reduced the amount of ND4 expression up-
regulation induced by VV infection. The effects of the
nucleotide analogue Ara C, which blocks the replication
of vaccinia virus, on the up-regulation of ND4 expression
were also examined [25]. As shown in Fig. 2B, ara C (40
μg/ml) blocked the increase in ND4 expression induced
by VV infection.
Analysis of several nuclear genes encoding mitochondrial 
electron transport chain proteins after VV infection
Both ND4 and COII are mitochondrial genes whose pro-
tein products are part of the electron transport chain that
generates ATP in cells [31]. To determine whether other
mitochondrial electron transport chain proteins encoded
in the nucleus are also up-regulated after VV infection,
protein expression of four randomly selected genes
involved in electron transport chain was analyzed using
Western blotting analysis. Compared to the expression of
β-actin gene or ERK2 gene, no significant differences were
observed after VV infection (Fig. 3).
Intracellular ATP generation increased after vaccinia virus 
infection
As the above results (Fig. 1 and Fig. 3) suggest that at lease
some of the proteins involved in the electron transport
chain to generate ATP are up-regulated after VV infection,
the intracellular ATP concentration was measured. Com-
pared to mock-infected cells, ATP production was signifi-
cantly higher in host cells after virus infection (Fig. 4A and
Fig. 4B). Using M.O.I. = 1 of vaccinia virus (Fig. 4A) for
infection, compared to the ATP level of mock-infected
HeLa cells at each time point (as 100%), the ATP level 1
hr after virus infection was 99.7%, 116% after 4 hr (P =
0.324), 161% after 8 hr (P = 0.001), 149% after 10 hr (P
Western blotting analysis of ND4 expression in vaccinia virus  infected cells Figure 1
Western blotting analysis of ND4 expression in vac-
cinia virus infected cells. (A) The HeLa cells were infected 
with MOI = 1 (or 5 or 20) of vaccinia virus for various time 
periods, as indicated. ND4 expression (marked by an arrow) 
was analyzed by Western blotting. ERK2 protein was served 
as a loading control. Occasionally, two non-specific bands 
(one larger and one smaller than ND4, indicated by thin 
lines) were detected in the samples. (B) ND4 was also up-
regulated in HuH7 cells after vaccinia virus infection. The 
ND4 protein is marked by an arrow while a non-specific 
band is indicated by a thin line.
Western blotting analysis of drug effects on ND4 expression  in VV infected cells Figure 2
Western blotting analysis of drug effects on ND4 
expression in VV infected cells. (A) HeLa cells were 
infected with VV (MOI = 1) for the indicated times in the 
presence or absence of 45 μM apigenin. Actin was used as a 
loading control. (B) The ND4 up-regulation by vaccinia virus 
infection (MOI = 1) was inhibited by the DNA polymerase 
inhibitor, ara C. Cells were incubated with ara C (40 μg/ml), 
an inhibitor of poxviral DNA synthesis, 30 min before VV 
infection and throughout the infection. The ND4 protein is 
indicated with an arrow while non-specific bands are indi-
cated by thin lines. ERK2 protein was used as a loading con-
trol.Journal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
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= 0.002), 150% after 12 hr (P = 0.011), 141% after 21 hr
(P = 0.018). Using M.O.I. = 5 of vaccinia virus (Fig. 4B) for
infection, compared to the ATP level of mock-infected
HeLa cells at each time point (as 100%), the ATP level 1
hr after virus infection was 104.6%, 120.3% after 4 hr (P
= 0.035), 132.1% after 8 hr (P = 0.193), 139.2% after 10
hr (P = 0.003), 153.7% after 12 hr (P = 0.078), 180.3%
after 21 hr (P = 0.018).
Oligomycin, an inhibitor of ATP generation, reduced the 
production of vaccinia virus
To determine whether this increased ATP production after
VV infection is necessary for virus production, oligomy-
cin, an inhibitor of ATP production, was used [32]. Com-
pared with the ATP level of non-treated HeLa cells (as
100%), the ATP level of virus-infected cells (M.O.I. = 1)
was 162% without oligomycin, 125% with 3 μM oligomy-
cin, 103% with 4.5 μM oligomycin, 88% with 6 μM oligo-
mycin, 68% with 7.5 μM oligomycin. Thus, treatment
with oligomycin at 4.5 μM reduced the ATP level in virus-
infected cells to that of mock-infected cells 13 hr after
infection (Fig. 5A). Therefore, 4.5 μM oligomycin was
used to evaluate the effect of increased ATP generation on
viral protein expression and virus production. Indeed, the
expression of two viral proteins (A type inclusion protein
and IMV heparin binding surface protein) was suppressed
in the presence of 4.5 μM oligomycin (Fig. 5B). The
number of intracellular mature virions was reduced to
about 28% (P = 0.01162) and extracellular enveloped vir-
ions to about 66% of control (P = 0.022722) (Fig. 5C) 13
hrs after virus infection. In contrast, the replication of
HCV sub-genomic RNA was not affected by 3, 6, 9, or 12
μM oligomycin (Additional file 3). Typically, oligomycin
has been used to block ATP production at a concentration
greater than 20 μM [32]. The intracellular ATP concentra-
tion of HeLa cells treated with 25 μM oligomycin was
reduced to about 50% that of non-treated cells (Addi-
tional file 4). When VV-infected cells were treated with 20
to 35 μM oligomycin, the intracellular ATP concentration
was reduced to about 50% of mock-infected cells 13 hr
after virus infection (Additional file 4), and the intracellu-
lar mature virions were reduced to about 10% of the level
in non-treated cells (data not shown).
Vaccinia virus infection induces ND4 expression through a 
Bcl-2 independent pathway
The Bcl-2 family of proteins are implicated in regulating
cellular bioenergetics, perhaps by regulating the availabil-
ity of mitochondrially produced ATP [33,34]. Western
blotting analysis was used to examine whether Bcl-2
expression is involved in the elevated ATP production
after VV infection. There was no up-regulation of Bcl-2 in
a comparison of mock-infected and virus-infected cells at
different time points. Moreover, Bcl-2 expression clearly
decreases at 21 hr post-infection when ATP production
and ND4 expression is optimally increased (Fig. 6A). Dif-
ferent shRNA clones against Bcl-2 were used to knock-
down its expression in HeLa cells (Fig. 6B). Clone 30 of
these shRNAs almost knocked-down Bcl-2 expression
entirely. However, HeLa cells stably transfected with this
shRNA could not survive anymore (data not shown).
Thus, HeLa cells with shRNA clone 31 against Bcl-2 were
used to evaluate the effect of Bcl-2 on the up-regulation of
ND4 and ATP generation after VV infection. Expression of
Bcl-2 protein in these cells was not affected by VV infec-
tion at different time points (Additional file 5). In these
Bcl-2 knock-downed cells, up-regulation of ND4 after VV
infection was still observed (Fig. 7A). ATP generation was
also increased after VV infection in these cells (Fig. 7B).
Vaccinia virus N1L protein was reported to have a similar
secondary (though not primary) structure to Bcl-2 protein
[35]. To determine whether N1L may be responsible for
the up-regulation of ND4 and COII after VV infection, the
N1L gene fragment was cloned and expressed in the cells.
No up-regulation of ND4 or COII was detected in the
presence of N1L protein (Additional file 6).
Discussion
In this study, at least some of the genes involved in ATP
generation were found to be up-regulated after VV infec-
tion (Fig. 1). Only two viral genes were detected in our
ddRT-PCR assay among about 200 proteins vaccinia virus
encoded (Additional file 1). Thus, only a small portion of
differentially genes was identified by this assay. Therefore,
it is not surprising that only ND4 and COII genes rather
Analysis of several nuclear genes encoding mitochondrial  electron transport chain proteins after VV infection by  Western blotting analysis Figure 3
Analysis of several nuclear genes encoding mitochon-
drial electron transport chain proteins after VV infec-
tion by Western blotting analysis. The Roman numbers 
in parentheses represent the respiratory complex in which 
the gene participates. ERK2 protein was used as a loading 
control.Journal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
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The intracellular ATP concentration was significantly increased after VV infection Figure 4
The intracellular ATP concentration was significantly increased after VV infection. Intracellular ATP concentration 
was measured at the indicated times (1, 4, 8, 10, 12, and 21 hr) after vaccinia virus infection in HeLa cells (MOI = 1 in Fig. 4A 
and MOI = 5 in Fig. 4B). Experiments were performed three times in duplicate.Journal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
Page 6 of 10
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(A) The intracellular ATP concentration of vaccinia virus infected (MOI = 1) and oligomycin-treated cells Figure 5
(A) The intracellular ATP concentration of vaccinia virus infected (MOI = 1) and oligomycin-treated cells. ATP 
concentration was measured 13 hrs after vaccinia virus infection in the presence of various concentration of oligomycin. Exper-
iments were performed three times in duplicate. (B) Western blotting analysis of Vaccinia viral protein expression (A type 
inclusion protein and IMV heparin binding surface protein) in the presence of 4.5 μM oligomycin. ERK2 protein was used as a 
loading control. (C) Both the intracellular and the extracellular vaccinia viruses were reduced 13 hr after virus infection in the 
presence of 4.5 μM oligomycin. Experiments of plague assay were performed three times in triplicate.Journal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
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than all 12 mRNA molecules in the same polycistronic
transcript were identified [31]. Host cell genes up-regu-
lated after vaccinia virus infection found in this study were
not the same as those found in previous microarray
assays, which suggests that ddRT-PCR and microarray
assays should be used in tandem for a more complete
analysis of differential gene expression between mock-
infected and virus-infected cells [7,8].
Our results demonstrate that ATP generation did increase
after vaccinia virus infection (Fig. 4). Our results (Figs. 1,
3, and 4) also indicate that increased ATP generation did
not require the up-regulation of all the proteins involved
in mitochondrial electron transport chain. Up-regulation
of mitochondrial-encoded rather than nuclear-encoded
proteins involved in mitochondrial electron transport
chain could increase ATP generation. This may suggest
that mitochondrial-encoded proteins rather than nuclear-
encoded ones involved in electron transport chain are
rate-determining proteins in ATP generation.
Our results demonstrate that increased ATP production is
essential for efficient VV production (Fig. 5). It is not sur-
prising that viral factors would modulate cellular energet-
ics to benefit the virus, though this area is understudied
[19]. To our knowledge, this study is the first report to
demonstrate that virus infection could up-regulate the
expression of genes involved in ATP generation and
increase ATP production. It is interesting to note that the
intracellular mature virions were more sensitive than the
extracellular enveloped virions to oligomycin treatment
(Fig. 5C). This may suggest that the assembly of intracel-
lular mature virions is more ATP-dependent [1].
ATP is required for the budding of influenza virus [16].
Similar up-regulation of ND4 expression after VV infec-
tion was not detected after replication of hepatitis B and C
viruses or infection with influenza A virus (Additional file
(A) The expression of Bcl-2 was not elevated during vaccinia  virus infection Figure 6
(A) The expression of Bcl-2 was not elevated during 
vaccinia virus infection. HeLa cells were infected with VV 
(MOI = 1) for the indicated times, then cell lysates were ana-
lyzed by Western blotting. ERK2 protein was used as a load-
ing control. (B) Western blotting analysis of Bcl-2 in HeLa 
cells stably transfected with different shRNA clones against 
Bcl-2. HeLa cells with shRNA against the Luciferase gene 
were used as a control. ERK2 protein was used as a loading 
control.
(A) Western blotting analysis of ND4 protein in vaccinia  virus-infected HeLa cells with shRNAs against Luc or Bcl-2 Figure 7
(A) Western blotting analysis of ND4 protein in vac-
cinia virus-infected HeLa cells with shRNAs against 
Luc or Bcl-2. ERK2 protein was used as a loading control. 
(B) Intracellular ATP concentration was measured at the 
indicated times (1, 4, 10, and 21 hr) after vaccinia infection of 
HeLa cells (MOI = 1). Experiments were performed three 
times in duplicate.Journal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
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2). One possibility is that there was no need to increase
ATP generation because there was already enough existing
energy source for multiplication of these viruses. Alterna-
tively, increased ATP generation in cells may still occur
here after infection with these viruses though the up-regu-
lation of ND4 is smaller than that caused by VV infection.
No amplification of mitochondrial DNA after vaccinia
virus infection was observed (data not shown). Therefore,
the up-regulation of ND4 after virus infection is possibly
through transcriptional regulation. However, little is
known about the regulation of mitochondrial transcrip-
tion [31]. Bcl-2 family proteins are implicated in regulat-
ing cellular bioenergetics, perhaps by regulating the
availability of mitochondrially produced ATP [33]. How-
ever, the amount of Bcl-2 protein in the host cell did not
increase after VV infection (Fig. 6A). Induction of ND4
protein and increased ATP generation are still occurred
after VV infection in HeLa cells with reduced amount of
Bcl-2 protein (Fig. 7A and 7B). VV N1L protein has been
reported to have similar secondary structure as Bcl-2 pro-
tein, but not primary structure, and may influence ATP
levels in vivo [35,36]. However, neither host ND4 nor
COII genes were up-regulated by N1L protein (Additional
file 6), which is consistent with a previous report showed
that N1L did not interact with mitochondria [37]. These
results indicate that increased ATP generation after VV
infection is a Bcl-2 independent event. Further studies are
needed to clarify the mechanism(s) of the up-regulation
of genes involved in ATP production after VV infection.
The up-regulation of ND4 expression was reduced by api-
genin and ara C (Fig. 2), suggesting that event(s) occurring
after viral DNA replication are responsible for the up-reg-
ulation of ND4 expression. These results are in agreement
with the observation that neither ND4 nor COII gene was
up-regulated by N1L protein (Additional file 6) since N1L
is an early gene product [1].
Conclusion
In summary, at least some of genes involved in ATP gen-
eration were up-regulated by VV infection, and in turn,
cellular ATP generation was increased. This increased ATP
generation was required for efficient VV production.
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Additional material
Additional file 1
Supplementary Fig. S1 - Gel analysis of ddRT-PCR products. DNA 
samples in different lanes represent the outcomes of different sets of prim-
ers for PCR (only four sets of primers out of 20 are shown). DNA frag-
ments (marked by arrows) selected to perform T/A cloning and sequencing 
were cytochrome c oxidase subunt II gene product (lane 2); VV gene prod-
ucts (lanes 4, 6); NADH dehydrogenase subunit IV gene product (lane 
8). C: mock-infected HeLa cell; V: 21 hr after vaccinia virus infection 
(MOI = 1) in HeLa cells.




Supplementary Fig. S2. - Western blotting analysis of ND4 protein 
expression. Samples were prepared from VV-infected HeLa cells, influ-
enza A virus-infected MDCK cells, HCV replicon cells (with sub-genomic 
HCV RNA), con1 cells (with full-length HCV RNA) and 1.3 × ES2 cells 
(with HBV genome). Mock-infected (MDCK cells) or non-transfected 
parental cells (HuH7 and HepG2 cells) were used as controls. ERK2 pro-
tein was used as a loading control.




Supplementary Fig. 3. - Western blotting analysis of NS5A to reflect 
the amount of HCV sub-genomic RNA. Lane 1, parental HuH7 cell; 
lane 2, HCV sub-genomic replicon without oligomycin; lane 3, HCV sub-
genomic replicon with 3 μM oligomycin; lane 4, HCV sub-genomic repli-
con with 6 μM oligomycin; lane 5, HCV sub-genomic replicon with 9 μM 
oligomycin; lane 6, HCV sub-genomic replicon with 12 μM oligomycin. 
Western blotting was performed 24 hr after oligomycin treatment. Erk-2 
protein was used as a loading control.




Supplementary Fig. 4. - Intracellular ATP concentration was meas-
ured 13 hr after VV infection (MOI = 1) in the presence of different 
oligomycin concentrations. Experiments were performed in duplicate. 
Compared with the ATP level of non-infected and non-treated HeLa cells 
(as 100%), the ATP level of virus-infected cells was 164% without oligo-
mycin, 49% with 20 μM oligomycin, 52% with 25 μM oligomycin, 
49.5% with 30 μM oligomycin, and 52.6% with 35 μM oligomycin. The 
ATP level was reduced to 58.5% in the presence of 25 μM oligomycin in 
mock-infected HeLa cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1423-
0127-16-80-S4.tiff]Journal of Biomedical Science 2009, 16:80 http://www.jbiomedsci.com/content/16/1/80
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